Kala’s Third Phase III Trial Should Line Up Approval In Dry Eye

 
• By Joseph Haas
  
Concept of eyesight, closeup of one eye with a target centred
Kala is targeting approval of Eysuvis by year's end in dry eye disease
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip